General MedicationsTRANSDERMALStandard
ELESTRIN
ESTRADIOL
Standard Dose
0.06% (0.87GM/ACTIVATION)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ELESTRIN is listed in Drugs@FDA under application 021813 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ESTRADIOL Form and strength GEL, METERED;TRANSDERMAL - 0.06% (0.87GM/ACTIVATION) Sponsor VIATRIS Submission history Latest submission status date: 2024-02-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview ELESTRIN is listed in Drugs@FDA under application 021813 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ESTRADIOL Form and strength GEL, METERED;TRANSDERMAL - 0.06% (0.87GM/ACTIVATION) Sponsor VIATRIS Submission history Latest submission status date: 2024-02-15 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.